This company listing is no longer active
ACUVI BTA Stock Overview
Provides components and systems solutions for motion and positioning in Sweden and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Acuvi AB Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 13.30 |
52 Week High | SEK 15.00 |
52 Week Low | SEK 13.20 |
Beta | 1.05 |
11 Month Change | n/a |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -5.67% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
ACUVI BTA | SE Electrical | SE Market | |
---|---|---|---|
7D | -5.0% | -6.1% | -1.5% |
1Y | n/a | 8.0% | 23.4% |
Return vs Industry: Insufficient data to determine how ACUVI BTA performed against the Swedish Electrical industry.
Return vs Market: Insufficient data to determine how ACUVI BTA performed against the Swedish Market.
Price Volatility
ACUVI BTA volatility | |
---|---|
ACUVI BTA Average Weekly Movement | n/a |
Electrical Industry Average Movement | 9.1% |
Market Average Movement | 5.5% |
10% most volatile stocks in SE Market | 11.4% |
10% least volatile stocks in SE Market | 3.3% |
Stable Share Price: ACUVI BTA has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ACUVI BTA's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1997 | 55 | Olof Stranding | www.acuvi.com |
Acuvi AB provides components and systems solutions for motion and positioning in Sweden and internationally. The company provides solutions in the field of life science instrumentation, semicon, medtech, and advanced industrial. Its products are primarily used in advanced microscopy and imaging, microfluids, semiconductor, manufacturing, and advanced optics.
Acuvi AB Fundamentals Summary
ACUVI BTA fundamental statistics | |
---|---|
Market cap | SEK 351.14m |
Earnings (TTM) | -SEK 65.09m |
Revenue (TTM) | SEK 211.93m |
1.7x
P/S Ratio-5.4x
P/E RatioIs ACUVI BTA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ACUVI BTA income statement (TTM) | |
---|---|
Revenue | SEK 211.93m |
Cost of Revenue | SEK 89.52m |
Gross Profit | SEK 122.41m |
Other Expenses | SEK 187.50m |
Earnings | -SEK 65.09m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -2.54 |
Gross Margin | 57.76% |
Net Profit Margin | -30.71% |
Debt/Equity Ratio | 20.0% |
How did ACUVI BTA perform over the long term?
See historical performance and comparison